Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Amyloid Fibrils03:03

Amyloid Fibrils

9.0K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

128
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
128
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

317
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
317

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Associations of circulating resistin with Alzheimer's disease biomarkers and cognitive function in the preclinical stage of Alzheimer's disease.

Journal of Alzheimer's disease : JAD·2026
Same author

Plasma glial fibrillary acidic protein as a biomarker of acute focal brain injury after high-intensity focused ultrasound thalamotomy.

Brain communications·2025
Same author

A preliminary study on plasma markers across cognitive stages and links to a history of mild traumatic brain injury.

Journal of Alzheimer's disease : JAD·2025
Same author

Functional classification of tauopathy strains reveals the role of protofilament core residues.

Science advances·2025
Same author

Essential tremor with tau pathology features seeds indistinguishable in conformation from Alzheimer's disease and primary age-related tauopathy.

bioRxiv : the preprint server for biology·2024
Same author

Exploring the association of disease-modifying therapies for multiple sclerosis and BTK inhibitors with epilepsy.

Therapeutic advances in neurological disorders·2024

相关实验视频

Updated: May 10, 2025

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

11.7K

补充水分以使粉样蛋白远离.

Nil Saez-Calveras1, Makoto Ishii1,2,3

  • 1Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Journal of Alzheimer's disease : JAD
|April 22, 2025
PubMed
概括

足够的每日液体摄入量可能对老年人大脑健康至关重要. 较低的水分水平与阿尔茨海默病 (ADRD) 生物标志物的增加有关,例如Aβ沉积和脑血管损伤.

关键词:
阿尔茨海默病的疾病阿尔茨海默病的疾病.粉样蛋白-β-β 的存在.大脑大脑大脑的大脑大脑影像成像技术 影像成像技术有关风险因素的风险因素.

更多相关视频

Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain
10:08

Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain

Published on: August 28, 2012

11.8K
Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
10:19

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Published on: August 14, 2016

9.2K

相关实验视频

Last Updated: May 10, 2025

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

11.7K
Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain
10:08

Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain

Published on: August 28, 2012

11.8K
Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
10:19

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Published on: August 14, 2016

9.2K

科学领域:

  • 老年学是一门学科.
  • 神经学 神经学
  • 神经科学是一个神经科学.

背景情况:

  • 老年人患脱水的风险更高.
  • 水分状况与阿尔茨海默氏症和相关痴呆症 (ADRD) 之间的联系尚未得到充分研究.
  • 摄入液体可能会影响认知健康和大脑衰老.

研究的目的:

  • 调查每日液体摄入量和ADRD神经成像生物标志物在认知正常的老年人之间的关联.
  • 为了探索水分在ADRD病变发生过程中的潜在作用.

主要方法:

  • 横截面研究分析了每日液体摄入量和神经成像数据 (Aβ沉积,脑血管损伤).
  • 参与者有287名认知正常的老年人.
  • 统计分析以确定液体摄入量和生物标志物之间的相关性.

主要成果:

  • 较低的每日液体摄入量与大脑粉样β (Aβ) 沉积的增加显著相关.
  • 流体摄入量减少与脑血管损伤标志物增加相关.
  • 这些发现表明,水分和ADRD病理之间存在潜在联系.

结论:

  • 补水可能是影响ADRD风险或进展的可修改因素.
  • 需要进一步的研究来确认因果关系并探索临床影响.
  • 在未来的ADRD研究和患者护理中,应考虑水合状况.